New product launch support for Japanese and Asian markets

Using the production capacity of our two factories in Japan, Bushu Pharma supports both Japanese and global pharmaceutical companies looking to launch their products in new markets.

We closely communicate with you from project kick-off to actual product launch, we will ensure we are the best par...

Bushu has followed PIC/S and GMP/GDP.
- QC test according to USP, EP, JP and Chinese pharmacopeia
- Serialization packaging for South Korea and others
- Control process room temperature within each country's regulations
- Storage for stability test for climate zone IVb

We manufacture formulation of high potency products ranging from clinical samples to pharmaceuticals Our manufacturing environment is based on hazard assessment, exposure assessment, and implementing strict residue management.

In addition, we monitor the environment and verify the containment b...

Many pharmaceutical and biologic drugs today are extremely sensitive to the conditions in which they are packaged, shipped and stored, with temperature deviations affecting the quality of product delivered. Bushu Pharma is skilled in the management of these factors and will ensure your products are handled...

- “Gateway to Asia” Contract Manufacturing Organization (CMO) Agreement to Double Volume of Drugs Produced for Amgen by Bushu Pharma -

Bushu Pharma's "Gateway to Asia" service supports customers in their desire to launch new products in Japan and across the larger Asian region. Our Gateway to Asia service lets international pharmaceutical companies import bulk products into Japan for quality inspection, labeling, packaging and distribution throughout Japan and other Asian countries. The service lets you focus on your core businesses and avoid having to deal with the difficult process of managing lead-time, temperature, security, inventory, packaging and urgent order handling across multiple markets.
Collectively, our services offers reduction of lead time from purchase order to shipping, financial and physical flow, oversight of inventory management for Asian markets, forecast review, and planning and operations based in GMP expertise.